ResearcherUniversity of GroningenActive in the last 2 years
Joost M. Klaase
Matched on ORCID iD 0000-0002-4409-2280; OpenAlex author ID A5064998999. Sources: OpenAlex.
Their work
- Papers
- 11 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 66
2016: 2 papers · 2017: 1 paper · 2018: none · 2019: 1 paper · 2020: 2 papers · 2021: 1 paper · 2022: none · 2023: 1 paper · 2024: none · 2025: 1 paper · 2026: 2 papers
Papers 11
- Contemporary challenges in long-term survival prediction in resected pancreatic ductal adenocarcinoma: a transatlantic multicenter development and validation o… Co-author DOI 10.1016/j.hpb.2026.04.453↗
- Surgical outcomes from nationwide implementation of the international best practice for locally advanced pancreatic cancer (PREOPANC-4) study. Co-author DOI 10.1093/bjs/znag075↗
- Preoperative Anemia as a Prognostic Risk Factor for Inferior Oncological Survival Following Resection for Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1097/mpa.0000000000002448↗
- Monitoring physical impact and recovery of pancreatic cancer treatment using consumer wearable health data: A case report. Last author DOI 10.1177/20552076231177127↗
- Neoadjuvant Treatment for Resectable and Borderline Resectable Pancreatic Cancer: Chemotherapy or Chemoradiotherapy? Co-author DOI 10.3389/fonc.2021.744161↗
- The ultimate preoperative C-reactive protein-to-albumin ratio is a prognostic factor for survival after pancreatic cancer resection. Last author DOI 10.1186/s40001-020-00444-z↗
- Conditional Survival After Resection for Pancreatic Cancer: A Population-Based Study and Prediction Model. Co-author DOI 10.1245/s10434-020-08235-w↗
- Safety of radiofrequency ablation in patients with locally advanced, unresectable pancreatic cancer: A phase II study. Co-author DOI 10.1016/j.ejso.2019.06.008↗
- Nationwide prospective audit of pancreatic surgery: design, accuracy, and outcomes of the Dutch Pancreatic Cancer Audit. Co-author DOI 10.1016/j.hpb.2017.06.010↗
- Preoperative radiochemotherapy versus immediate surgery for resectable and borderline resectable pancreatic cancer (PREOPANC trial): study protocol for a multi… Co-author DOI 10.1186/s13063-016-1262-z↗
- Outcomes of Distal Pancreatectomy for Pancreatic Ductal Adenocarcinoma in the Netherlands: A Nationwide Retrospective Analysis. Co-author DOI 10.1245/s10434-015-4930-4↗
Closest collaborators
The 25 strongest of 66 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Ignace H. J. T. de Hingh · 7 shared papers, 2016–2026 · strength 0.63
- Paper Contemporary challenges in long-term survival prediction in resected pancreatic ductal adenocarcinoma: a transatlantic … DOI 10.1016/j.hpb.2026.04.453↗
- Paper Neoadjuvant Treatment for Resectable and Borderline Resectable Pancreatic Cancer: Chemotherapy or Chemoradiotherapy? DOI 10.3389/fonc.2021.744161↗
- Paper Conditional Survival After Resection for Pancreatic Cancer: A Population-Based Study and Prediction Model. DOI 10.1245/s10434-020-08235-w↗
- Hjalmar C. van Santvoort · 5 shared papers, 2016–2026 · strength 0.49
- Paper Contemporary challenges in long-term survival prediction in resected pancreatic ductal adenocarcinoma: a transatlantic … DOI 10.1016/j.hpb.2026.04.453↗
- Paper Neoadjuvant Treatment for Resectable and Borderline Resectable Pancreatic Cancer: Chemotherapy or Chemoradiotherapy? DOI 10.3389/fonc.2021.744161↗
- Paper Safety of radiofrequency ablation in patients with locally advanced, unresectable pancreatic cancer: A phase II study. DOI 10.1016/j.ejso.2019.06.008↗
- Izaak Quintus Molenaar · 6 shared papers, 2016–2026 · strength 0.49
- Paper Contemporary challenges in long-term survival prediction in resected pancreatic ductal adenocarcinoma: a transatlantic … DOI 10.1016/j.hpb.2026.04.453↗
- Paper Conditional Survival After Resection for Pancreatic Cancer: A Population-Based Study and Prediction Model. DOI 10.1245/s10434-020-08235-w↗
- Paper Safety of radiofrequency ablation in patients with locally advanced, unresectable pancreatic cancer: A phase II study. DOI 10.1016/j.ejso.2019.06.008↗
- Marc G. Besselink · 6 shared papers, 2016–2026 · strength 0.49
- Paper Contemporary challenges in long-term survival prediction in resected pancreatic ductal adenocarcinoma: a transatlantic … DOI 10.1016/j.hpb.2026.04.453↗
- Paper Conditional Survival After Resection for Pancreatic Cancer: A Population-Based Study and Prediction Model. DOI 10.1245/s10434-020-08235-w↗
- Paper Safety of radiofrequency ablation in patients with locally advanced, unresectable pancreatic cancer: A phase II study. DOI 10.1016/j.ejso.2019.06.008↗
- Gijs A. Patijn · 5 shared papers, 2016–2026 · strength 0.47
- Paper Contemporary challenges in long-term survival prediction in resected pancreatic ductal adenocarcinoma: a transatlantic … DOI 10.1016/j.hpb.2026.04.453↗
- Paper The ultimate preoperative C-reactive protein-to-albumin ratio is a prognostic factor for survival after pancreatic canc… DOI 10.1186/s40001-020-00444-z↗
- Paper Nationwide prospective audit of pancreatic surgery: design, accuracy, and outcomes of the Dutch Pancreatic Cancer Audit. DOI 10.1016/j.hpb.2017.06.010↗
- Maarten W. Nijkamp · 2 shared papers, 2025–2026 · strength 0.42
- Paper Preoperative Anemia as a Prognostic Risk Factor for Inferior Oncological Survival Following Resection for Pancreatic Du… DOI 10.1097/mpa.0000000000002448↗
- Paper Contemporary challenges in long-term survival prediction in resected pancreatic ductal adenocarcinoma: a transatlantic … DOI 10.1016/j.hpb.2026.04.453↗
- Casper H.J. van Eijck · 5 shared papers, 2016–2026 · strength 0.41
- Paper Contemporary challenges in long-term survival prediction in resected pancreatic ductal adenocarcinoma: a transatlantic … DOI 10.1016/j.hpb.2026.04.453↗
- Paper Conditional Survival After Resection for Pancreatic Cancer: A Population-Based Study and Prediction Model. DOI 10.1245/s10434-020-08235-w↗
- Paper Nationwide prospective audit of pancreatic surgery: design, accuracy, and outcomes of the Dutch Pancreatic Cancer Audit. DOI 10.1016/j.hpb.2017.06.010↗
- Bas Groot Koerkamp · 3 shared papers, 2017–2026 · strength 0.32
- Paper Contemporary challenges in long-term survival prediction in resected pancreatic ductal adenocarcinoma: a transatlantic … DOI 10.1016/j.hpb.2026.04.453↗
- Paper Conditional Survival After Resection for Pancreatic Cancer: A Population-Based Study and Prediction Model. DOI 10.1245/s10434-020-08235-w↗
- Paper Nationwide prospective audit of pancreatic surgery: design, accuracy, and outcomes of the Dutch Pancreatic Cancer Audit. DOI 10.1016/j.hpb.2017.06.010↗
- Geert Kazemier M · 3 shared papers, 2016–2026 · strength 0.28
- Paper Contemporary challenges in long-term survival prediction in resected pancreatic ductal adenocarcinoma: a transatlantic … DOI 10.1016/j.hpb.2026.04.453↗
- Paper Nationwide prospective audit of pancreatic surgery: design, accuracy, and outcomes of the Dutch Pancreatic Cancer Audit. DOI 10.1016/j.hpb.2017.06.010↗
- Paper Outcomes of Distal Pancreatectomy for Pancreatic Ductal Adenocarcinoma in the Netherlands: A Nationwide Retrospective A… DOI 10.1245/s10434-015-4930-4↗
- Martijn W.J. Stommel · 2 shared papers, 2020–2026 · strength 0.28
- Paper Contemporary challenges in long-term survival prediction in resected pancreatic ductal adenocarcinoma: a transatlantic … DOI 10.1016/j.hpb.2026.04.453↗
- Paper Conditional Survival After Resection for Pancreatic Cancer: A Population-Based Study and Prediction Model. DOI 10.1245/s10434-020-08235-w↗
- Cees P. van der Schans · 1 shared paper, 2023 · strength 0.24
- Mylena D. Bos · 1 shared paper, 2025 · strength 0.24
- Maximilian Bockhorn · 1 shared paper, 2025 · strength 0.24
- N. Helge Meyer · 1 shared paper, 2025 · strength 0.24
- Allard G Wijma · 1 shared paper, 2025 · strength 0.24
- Christopher Lee Wolfgang · 2 shared papers, 2017–2026 · strength 0.23
- Paper Contemporary challenges in long-term survival prediction in resected pancreatic ductal adenocarcinoma: a transatlantic … DOI 10.1016/j.hpb.2026.04.453↗
- Paper Nationwide prospective audit of pancreatic surgery: design, accuracy, and outcomes of the Dutch Pancreatic Cancer Audit. DOI 10.1016/j.hpb.2017.06.010↗
- Sebastiaan Festen · 2 shared papers, 2016–2026 · strength 0.23
- Paper Contemporary challenges in long-term survival prediction in resected pancreatic ductal adenocarcinoma: a transatlantic … DOI 10.1016/j.hpb.2026.04.453↗
- Paper Preoperative radiochemotherapy versus immediate surgery for resectable and borderline resectable pancreatic cancer (PRE… DOI 10.1186/s13063-016-1262-z↗
- Geertjan van Tienhoven · 3 shared papers, 2016–2021 · strength 0.22
- Paper Neoadjuvant Treatment for Resectable and Borderline Resectable Pancreatic Cancer: Chemotherapy or Chemoradiotherapy? DOI 10.3389/fonc.2021.744161↗
- Paper Nationwide prospective audit of pancreatic surgery: design, accuracy, and outcomes of the Dutch Pancreatic Cancer Audit. DOI 10.1016/j.hpb.2017.06.010↗
- Paper Preoperative radiochemotherapy versus immediate surgery for resectable and borderline resectable pancreatic cancer (PRE… DOI 10.1186/s13063-016-1262-z↗
- Johanna W. Wilmink · 2 shared papers, 2020–2021 · strength 0.22
- Marjolein Y.V. Homs · 2 shared papers, 2020–2021 · strength 0.22
- Bert A. Bonsing · 4 shared papers, 2016–2020 · strength 0.22
- Paper Conditional Survival After Resection for Pancreatic Cancer: A Population-Based Study and Prediction Model. DOI 10.1245/s10434-020-08235-w↗
- Paper Nationwide prospective audit of pancreatic surgery: design, accuracy, and outcomes of the Dutch Pancreatic Cancer Audit. DOI 10.1016/j.hpb.2017.06.010↗
- Paper Outcomes of Distal Pancreatectomy for Pancreatic Ductal Adenocarcinoma in the Netherlands: A Nationwide Retrospective A… DOI 10.1245/s10434-015-4930-4↗
- William Reece Burns · 1 shared paper, 2026 · strength 0.19
- Nabiha Akhlaq Mughal · 1 shared paper, 2026 · strength 0.19
- Giuseppe Malleo · 1 shared paper, 2026 · strength 0.19
- Thijs J. Schouten · 1 shared paper, 2026 · strength 0.19
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.